Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CRYSTAL LYNNETTE MINOR

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health

NPI
1750927893
CMS profile
11197988
Location
OXFORD, NC

General Payments · PY2021–2024

$1,332.76

  • Reported across 52 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$356.88

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $356.88 17

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $153.80 9
SHIELD THERAPEUTICS INC $84.00 2
Organon LLC $51.69 2
Astellas Pharma US Inc $37.44 2
Novo Nordisk AS $29.95 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $322.12 12
PY2022 $325.15 9
PY2023 $328.61 14
PY2024 $356.88 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $19.16 08/12/2024 Food and Beverage Undisputed 01/23/2026 1139462578 CMS
Astellas Pharma US Inc $18.28 10/10/2024 Food and Beverage Undisputed 01/23/2026 1139538302 CMS
Novo Nordisk Inc $15.88 01/09/2024 Food and Beverage Undisputed 01/23/2026 1100400315 CMS
Novo Nordisk Inc $14.07 02/06/2024 Food and Beverage Undisputed 01/23/2026 1100374415 CMS
Organon Llc $24.72 01/11/2024 Food and Beverage Undisputed 01/23/2026 1136293317 CMS
Organon Llc $26.97 04/30/2024 Food and Beverage Undisputed 01/23/2026 1136316845 CMS
PFIZER INC. $17.26 01/24/2024 Food and Beverage Undisputed 01/23/2026 1131156410 CMS
PFIZER INC. $14.56 02/13/2024 Food and Beverage Undisputed 01/23/2026 1131153425 CMS
PFIZER INC. $15.38 03/12/2024 Food and Beverage Undisputed 01/23/2026 1131156405 CMS
PFIZER INC. $20.47 04/05/2024 Food and Beverage Undisputed 01/23/2026 1131626465 CMS
PFIZER INC. $18.26 04/17/2024 Food and Beverage Undisputed 01/23/2026 1131239919 CMS
PFIZER INC. $15.63 04/17/2024 Food and Beverage Undisputed 01/23/2026 1131337900 CMS
PFIZER INC. $17.72 07/25/2024 Food and Beverage Undisputed 01/23/2026 1131626469 CMS
PFIZER INC. $18.20 09/30/2024 Food and Beverage Undisputed 01/23/2026 1131932268 CMS
PFIZER INC. $16.32 11/04/2024 Food and Beverage Undisputed 01/23/2026 1132132511 CMS
SHIELD THERAPEUTICS INC $39.62 10/16/2024 Food and Beverage Undisputed 01/23/2026 1150149863 CMS
SHIELD THERAPEUTICS INC $44.38 11/07/2024 Food and Beverage Undisputed 01/23/2026 1150153094 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.